◼ Archived
Health
A precision T-cell therapy stalls treatment-resistant cancers in clinical trial
Marengo Therapeutics' Invikafusp alfa shows promise in treating TMB-H solid tumors resistant to standard immune checkpoint blockade.
T-Cell
5 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engager
Novartis has agreed to a massive new mRNA drug deal with Chinese startup Abogen worth up to $7.8 billion.
◼ Archived
Health
Scientists find the gene that drives T-cell exhaustion, revealing new strategy to improve immune responses
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
UCLA’s $5,000 T-Cell Therapy Could Upend Solid-Tumor Cancer Treatment
UCLA scientists have developed a method to convert cord blood into powerful T cells designed to fight solid-tumor cancers at a cost of $5,000.
◼ Archived
Health
🔮 fades ✓
Personalized T-cell therapy eliminates detectable metastatic kidney tumor in adolescent after multiple relapses
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.